US Patent 7473416 Medicaments for asthma treatment

Patent 7473416 was granted and assigned to Britannia Pharmaceuticals on January, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Britannia Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

74734160

Patent Inventor Names

Derek Alan Woodcock0

Date of Patent

January 6, 2009

Patent Application Number

109767570

Date Filed

November 1, 2004

Patent Primary Examiner

‌

Johann R. Richter

Patent abstract

A method and apparatus are disclosed for treating asthma and other respiratory conditions. A medicament comprising a surface active phospholipid (SAPL) is prepared in the form of a fine powder and administered to the lungs in a gas stream. A preferred SAPL is a solid blend of diplamitoyl choline and phosphatdiyl glycerol (PG).